Kirenol (Kirel) is a natural product extracted from Siegesbeckia orientalis with a variety of biological effects such as anti-inflammatory, antitumor, anti-oxidant, anti-allergic, and anti-arthritic activities. It is effective against gram-positive bacteria and exhibits anticancer activity against human chronic myeloid leukemia K562 cells in vitro. Kirenol is capable of promoting osteoblast differentiation in MC3T3-E1 cells through activation of the BMP and Wnt/β-catenin signaling pathways. Kirenol can reduce pro-inflammatory cytokine secretion, increase anti-inflammatory cytokine production, inhibitcell proliferation and induce apoptosis of CII-specific lymphocytes in vitro.
Physicochemical Properties
| Molecular Formula | C20H34O4 |
| Molecular Weight | 338.49 |
| Exact Mass | 338.245 |
| CAS # | 52659-56-0 |
| PubChem CID | 15736732 |
| Appearance | Off-white to light yellow solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 516.9±35.0 °C at 760 mmHg |
| Melting Point | 197.0 to 201.0 °C |
| Flash Point | 233.6±20.5 °C |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.570 |
| LogP | 1.78 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 24 |
| Complexity | 518 |
| Defined Atom Stereocenter Count | 7 |
| SMILES | C[C@@]1(CC[C@@H]2C(=C1)CC[C@H]3[C@]2(C[C@@H](C[C@@]3(C)CO)O)C)[C@H](CO)O |
| InChi Key | NRYNTARIOIRWAB-JPDRSCFKSA-N |
| InChi Code | InChI=1S/C20H34O4/c1-18(17(24)11-21)7-6-15-13(8-18)4-5-16-19(2,12-22)9-14(23)10-20(15,16)3/h8,14-17,21-24H,4-7,9-12H2,1-3H3/t14-,15-,16-,17+,18+,19+,20+/m1/s1 |
| Chemical Name | (1R)-1-[(2S,4aR,4bS,6S,8R,8aS)-6-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-2-yl]ethane-1,2-diol |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
1.Topical anti-inflammatory and analgesic activity of kirenol isolated from Siegesbeckia orientalis, Journal of Ethnopharmacology, Volume 137, Issue 3, 2011, Pages 1089-1094, ISSN 0378-8741. 2.Kirenol\nAttenuates Experimental Autoimmune Encephalomyelitis by Inhibiting\nDifferentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector\nT Cells[J]. Scientific Reports, 2015, 5(1):9022. |
| Additional Infomation |
Kirenol is a diterpenoid. Kirenol has been reported in Sigesbeckia glabrescens, Sigesbeckia orientalis, and Sigesbeckia pubescens with data available. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~295.44 mM) H2O : < 0.1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 3.25 mg/mL (9.60 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 3.25 mg/mL (9.60 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 3.25 mg/mL (9.60 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9543 mL | 14.7715 mL | 29.5430 mL | |
| 5 mM | 0.5909 mL | 2.9543 mL | 5.9086 mL | |
| 10 mM | 0.2954 mL | 1.4771 mL | 2.9543 mL |